Winnebago Gears Up For Q1 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Benzinga

Published Dec 20, 2023 06:49

Updated Dec 20, 2023 08:10

Winnebago Gears Up For Q1 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Winnebago Industries, Inc. (NYSE: WGO) is projected to release financial results for its first quarter fiscal 2024, before the opening bell on Dec. 20, 2023.

Analysts expect the company to post quarterly earnings at $1.17 per share, down from year-ago earnings of $2.07 per share. The company’s revenue might come in at $723.82 million for the latest quarter, compared to $857.38 million in the year-earlier period, according to Benzinga Pro.

The company’s board recently approved a quarterly cash dividend of 31 cents per share payable on Jan. 26, 2024, to common stockholders of record at the close of business on Jan. 12, 2024.

Winnebago Industries shares gained 2.8% to close at $75.14 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • BMO Capital analyst Tristan Thomas-Martin maintained an Outperform rating and cut the price target from $85 to $80 on Oct. 19, 2023. This analyst has an accuracy rate of 67%.
  • Roth MKM analyst Scott Stember maintained a Neutral rating and lowered the price target from $61 to $58 on Oct. 19, 2023. This analyst has an accuracy rate of 64%.
  • Citigroup analyst James Hardiman maintained a Buy rating and cut the price target from $77 to $73 on Oct. 17, 2023. This analyst has an accuracy rate of 64%.
  • Truist Securities analyst Michael Swartz maintained a Buy rating and cut the price target from $75 to $74 on Sept. 15, 2023. This analyst has an accuracy rate of 76%.
  • Northcoast Research analyst John Healy downgraded the stock from Buy to Neutral on Feb. 6, 2023. This analyst has an accuracy rate of 75%.

Read This Next: Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying

Latest Ratings for WGO

DateFirmActionFromTo
Jan 2022CL KingUpgradesNeutralStrong Buy
Oct 2021KeybancDowngradesOverweightSector Weight
Oct 2021KeybancDowngradesOverweightSector Weight
View More Analyst Ratings for WGO

View the Latest Analyst Ratings

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Get The App
Join the millions of people who stay on top of global financial markets with Investing.com.
Download Now

Read the original article on Benzinga

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes